FRANKLIN WIRELESS CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that FRANKLIN WIRELESS CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $46.09M | Sep 29, 2025 |
| FY2025 | Jun 30, 2024 | $30.80M | Sep 29, 2025 |
| FY2024 | Jun 30, 2023 | $45.95M | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | $24.00M | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $184.12M | Sep 13, 2022 |
| FY2021 | Jun 30, 2020 | $75.07M | Sep 28, 2021 |
| FY2020 | Jun 30, 2019 | $36.47M | Sep 18, 2020 |
| FY2019 | Jun 30, 2018 | $30.07M | Sep 30, 2019 |
| FY2018 | Jun 30, 2017 | $48.57M | Sep 28, 2018 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $7.92M | Sep 29, 2025 |
| FY2025 | Jun 30, 2024 | $3.51M | Sep 29, 2025 |
| FY2024 | Jun 30, 2023 | $7.02M | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | $3.82M | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $32.46M | Sep 13, 2022 |
| FY2021 | Jun 30, 2020 | $14.52M | Sep 28, 2021 |
| FY2020 | Jun 30, 2019 | $5.74M | Sep 18, 2020 |
| FY2019 | Jun 30, 2018 | $5.19M | Sep 30, 2019 |
| FY2018 | Jun 30, 2017 | $9.22M | Sep 28, 2018 |
| FY2017 | Jun 30, 2016 | $9.93M | Sep 28, 2017 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($243.1K) | Sep 29, 2025 |
| FY2025 | Jun 30, 2024 | ($3.96M) | Sep 29, 2025 |
| FY2024 | Jun 30, 2023 | ($2.86M) | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | ($3.76M) | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $17.70M | Sep 13, 2022 |
| FY2021 | Jun 30, 2020 | $5.55M | Sep 28, 2021 |
| FY2020 | Jun 30, 2019 | ($1.28M) | Sep 18, 2020 |
| FY2019 | Jun 30, 2018 | ($2.09M) | Sep 30, 2019 |
| FY2018 | Jun 30, 2017 | $874.0K | Sep 28, 2018 |
| FY2017 | Jun 30, 2016 | $1.61M | Sep 28, 2017 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($2.86M) | Sep 29, 2025 |
| FY2025 | Jun 30, 2024 | ($5.94M) | Sep 29, 2025 |
| FY2024 | Jun 30, 2023 | ($2.35M) | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | ($4.97M) | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $22.82M | Sep 13, 2022 |
| FY2021 | Jun 30, 2020 | $7.08M | Sep 28, 2021 |
| FY2020 | Jun 30, 2019 | ($2.11M) | Sep 18, 2020 |
| FY2019 | Jun 30, 2018 | ($2.69M) | Sep 30, 2019 |
| FY2018 | Jun 30, 2017 | $874.4K | Sep 28, 2018 |
| FY2017 | Jun 30, 2016 | $2.12M | Sep 28, 2017 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $4.10M | Sep 29, 2025 |
| FY2025 | Jun 30, 2024 | $3.41M | Sep 29, 2025 |
| FY2024 | Jun 30, 2023 | $3.92M | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | $4.28M | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $4.57M | Sep 13, 2022 |
| FY2021 | Jun 30, 2020 | $3.75M | Sep 28, 2021 |
| FY2020 | Jun 30, 2019 | $2.96M | Sep 18, 2020 |
| FY2019 | Jun 30, 2018 | $3.37M | Sep 30, 2019 |
| FY2018 | Jun 30, 2017 | $3.45M | Sep 28, 2018 |
| FY2017 | Jun 30, 2016 | $2.99M | Sep 28, 2017 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $6.68M | Sep 29, 2025 |
| FY2025 | Jun 30, 2024 | $6.04M | Sep 29, 2025 |
| FY2024 | Jun 30, 2023 | $5.45M | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | $4.51M | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $5.08M | Sep 13, 2022 |
| FY2021 | Jun 30, 2020 | $3.70M | Sep 28, 2021 |
| FY2020 | Jun 30, 2019 | $4.89M | Sep 18, 2020 |
| FY2019 | Jun 30, 2018 | $4.51M | Sep 30, 2019 |
| FY2018 | Jun 30, 2017 | $4.90M | Sep 28, 2018 |
| FY2017 | Jun 30, 2016 | $4.82M | Sep 28, 2017 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $1.84M | Sep 29, 2025 |
| FY2025 | Jun 30, 2024 | ($773.4K) | Sep 29, 2025 |
| FY2024 | Jun 30, 2023 | ($1.88M) | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | ($7.41M) | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $12.10M | Sep 13, 2022 |
| FY2021 | Jun 30, 2020 | $22.00M | Sep 28, 2021 |
| FY2020 | Jun 30, 2019 | $775.1K | Sep 18, 2020 |
| FY2019 | Jun 30, 2018 | ($2.01M) | Sep 30, 2019 |
| FY2018 | Jun 30, 2017 | $1.49M | Sep 28, 2018 |
| FY2017 | Jun 30, 2016 | $2.71M | Sep 28, 2017 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $32.8K | Sep 29, 2025 |
| FY2025 | Jun 30, 2024 | $55.0K | Sep 29, 2025 |
| FY2024 | Jun 30, 2023 | $47.1K | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | $42.1K | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $21.0K | Sep 13, 2022 |
| FY2021 | Jun 30, 2020 | $181.7K | Sep 28, 2021 |
| FY2020 | Jun 30, 2019 | $100.8K | Sep 18, 2020 |
| FY2019 | Jun 30, 2018 | $23.9K | Sep 30, 2019 |
| FY2018 | Jun 30, 2017 | $45.4K | Sep 28, 2018 |
| FY2017 | Jun 30, 2016 | $173.2K | Sep 28, 2017 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $51.33M | Sep 29, 2025 |
| FY2025 | Jun 30, 2024 | $46.72M | Sep 29, 2025 |
| FY2024 | Jun 30, 2023 | $56.93M | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | $52.04M | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $57.79M | Sep 13, 2022 |
| FY2021 | Jun 30, 2020 | $65.39M | Sep 28, 2021 |
| FY2020 | Jun 30, 2019 | $21.20M | Sep 18, 2020 |
| FY2019 | Jun 30, 2018 | $25.14M | Sep 30, 2019 |
| FY2018 | Jun 30, 2017 | $32.31M | Sep 28, 2018 |
| FY2017 | Jun 30, 2016 | $31.75M | Sep 28, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $13.44M | Sep 29, 2025 |
| FY2025 | Jun 30, 2024 | $10.34M | Sep 29, 2025 |
| FY2024 | Jun 30, 2023 | $16.51M | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | $9.44M | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $11.62M | Sep 13, 2022 |
| FY2021 | Jun 30, 2020 | $44.26M | Sep 28, 2021 |
| FY2020 | Jun 30, 2019 | $5.92M | Sep 18, 2020 |
| FY2019 | Jun 30, 2018 | $8.10M | Sep 30, 2019 |
| FY2018 | Jun 30, 2017 | $13.20M | Sep 28, 2018 |
| FY2017 | Jun 30, 2016 | $13.53M | Sep 28, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $34.54M | Sep 29, 2025 |
| FY2025 | Jun 30, 2024 | $35.15M | Sep 29, 2025 |
| FY2024 | Jun 30, 2023 | $38.93M | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | $41.03M | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $44.69M | Sep 13, 2022 |
| FY2021 | Jun 30, 2020 | $20.35M | Sep 28, 2021 |
| FY2020 | Jun 30, 2019 | $14.79M | Sep 18, 2020 |
| FY2019 | Jun 30, 2018 | $16.11M | Sep 30, 2019 |
| FY2018 | Jun 30, 2017 | $18.11M | Sep 28, 2018 |
| FY2017 | Jun 30, 2016 | $17.12M | Sep 28, 2017 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $273.3K | Sep 29, 2025 |
| FY2025 | Jun 30, 2024 | $273.3K | Sep 29, 2025 |
| FY2024 | Jun 30, 2023 | $273.3K | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | $273.3K | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $273.3K | Sep 13, 2022 |
| FY2021 | Jun 30, 2020 | $273.3K | Sep 28, 2021 |
| FY2020 | Jun 30, 2019 | $273.3K | Sep 18, 2020 |
| FY2019 | Jun 30, 2018 | $273.3K | Sep 30, 2019 |
| FY2018 | Jun 30, 2017 | $273.3K | Sep 28, 2018 |
| FY2017 | Jun 30, 2016 | $273.3K | Sep 28, 2017 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $24.89M | Sep 29, 2025 |
| FY2025 | Jun 30, 2024 | $25.14M | Sep 29, 2025 |
| FY2024 | Jun 30, 2023 | $29.10M | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | $31.96M | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $35.73M | Sep 13, 2022 |
| FY2021 | Jun 30, 2020 | $18.03M | Sep 28, 2021 |
| FY2020 | Jun 30, 2019 | $12.48M | Sep 18, 2020 |
| FY2019 | Jun 30, 2018 | $13.75M | Sep 30, 2019 |
| FY2018 | Jun 30, 2017 | $15.85M | Sep 28, 2018 |
| FY2017 | Jun 30, 2016 | $14.97M | Sep 28, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Jun 30, 2024 | $12.27M | Sep 30, 2024 |
| FY2024 | Jun 30, 2023 | $12.24M | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | $26.28M | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $45.80M | Sep 13, 2022 |
| FY2021 | Jun 30, 2020 | $28.16M | Sep 28, 2021 |
| FY2021 | Jun 30, 2019 | $6.45M | Sep 28, 2021 |
| FY2020 | Jun 30, 2018 | $11.98M | Sep 18, 2020 |
| FY2019 | Jun 30, 2017 | $14.29M | Sep 30, 2019 |
| FY2018 | Jun 30, 2016 | $13.16M | Sep 28, 2018 |
| FY2017 | Jun 30, 2015 | $11.82M | Sep 28, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 0 | Sep 29, 2025 |
| FY2025 | Jun 30, 2024 | 0 | Sep 29, 2025 |
| FY2024 | Jun 30, 2023 | 0 | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | 0 | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | 1 | Sep 13, 2022 |
| FY2021 | Jun 30, 2020 | 0 | Sep 28, 2021 |
| FY2020 | Jun 30, 2019 | 0 | Sep 18, 2020 |
| FY2019 | Jun 30, 2018 | 0 | Sep 30, 2019 |
| FY2018 | Jun 30, 2017 | 0 | Sep 28, 2018 |
| FY2017 | Jun 30, 2016 | 0 | Sep 28, 2017 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 0 | Sep 29, 2025 |
| FY2025 | Jun 30, 2024 | 0 | Sep 29, 2025 |
| FY2024 | Jun 30, 2023 | 0 | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | 0 | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | 1 | Sep 13, 2022 |
| FY2021 | Jun 30, 2020 | 0 | Sep 28, 2021 |
| FY2020 | Jun 30, 2019 | 0 | Sep 18, 2020 |
| FY2019 | Jun 30, 2018 | 0 | Sep 30, 2019 |
| FY2018 | Jun 30, 2017 | 0 | Sep 28, 2018 |
| FY2017 | Jun 30, 2016 | 0 | Sep 28, 2017 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 11.78M | Sep 29, 2025 |
| FY2025 | Jun 30, 2024 | 11.78M | Sep 29, 2025 |
| FY2024 | Jun 30, 2023 | 11.78M | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | 11.68M | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | 11.59M | Sep 13, 2022 |
| FY2021 | Jun 30, 2020 | 10.61M | Sep 28, 2021 |
| FY2020 | Jun 30, 2019 | 10.57M | Sep 18, 2020 |
| FY2019 | Jun 30, 2018 | 10.57M | Sep 30, 2019 |
| FY2018 | Jun 30, 2017 | 10.52M | Sep 28, 2018 |
| FY2017 | Jun 30, 2016 | 10.44M | Sep 28, 2017 |